STREAM

From Wiki Journal Club
Jump to: navigation, search
Armstrong PW, et al. "Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction". NEJM. 2013. 368(15):1379-87.
PubMedPDFClinicalTrials.gov

Clinical Question

Bottom Line

Major Points

Guidelines

As of June 2018, no guidelines have been published that reflect the results of this trial.

Design

  • Multicenter, open-label, parallel-group, randomized, controlled trial
  • N=
    • Intervention (n=)
    • Placebo (n=)
  • Setting:
  • Enrollment:
  • Mean follow-up:
  • Analysis:
  • Primary Outcome: 30-day composite of death from any cause, shock, congestive heart failure, or reinfarction

Population

Inclusion Criteria

Exclusion Criteria

Baseline Characteristics

BLANK Group displayed

  • Demographics:
  • Physiologic parameters:
  • Anthropomorphics: Weight
  • Labs:
  • Site of infection

Interventions

Outcomes

Comparisons are BLANK therapy vs. BLANK therapy.

Primary Outcomes

Secondary Outcomes

Subgroup Analysis

Adverse Events

Criticisms

Funding

Further Reading